Last update 21 Nov 2024

PB-101(Panolos Bioscience)

Overview

Basic Info

Drug Type
Antibody fusion proteins
Synonyms
Target
PIGF x VEGF-A x VEGF-B
Mechanism
PIGF inhibitors(Phosphatidylinositol glycan synthesis F inhibitors), VEGF-A inhibitors(Vascular endothelial growth factor A inhibitors), VEGF-B inhibitors(Vascular endothelial growth factor B inhibitors)
Therapeutic Areas
NeoplasmsDigestive System Disorders
Active Indication
Hepatocellular CarcinomaMetastatic Colorectal CarcinomaStomach Cancer+ [1]
Inactive Indication-
Originator Organization
Panolos Bioscience, Inc.Panolos Bioscience, Inc.
Active Organization
NeoImmuneTech, Inc.NeoImmuneTech, Inc.Panolos Bioscience, Inc.Panolos Bioscience, Inc.SAMSUNG BIOLOGICS Co., Ltd.SAMSUNG BIOLOGICS Co., Ltd.
Inactive Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with PB-101(Panolos Bioscience)
NCT06075849 / RecruitingPhase 1
A Multicenter, Open-label, Dose Escalation and Expansion, Phase I Study to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Anti-tumor Activity of PB101 in Patients With Advanced Solid Tumor
100 Clinical Results associated with PB-101(Panolos Bioscience)
Login to view more data
100 Translational Medicine associated with PB-101(Panolos Bioscience)
Login to view more data
100 Patents (Medical) associated with PB-101(Panolos Bioscience)
Login to view more data
100 Deals associated with PB-101(Panolos Bioscience)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Hepatocellular CarcinomaPhase 1
KR
Panolos Bioscience, Inc.Panolos Bioscience, Inc.
25 Oct 2023
Metastatic Colorectal CarcinomaPhase 1
KR
Panolos Bioscience, Inc.Panolos Bioscience, Inc.
25 Oct 2023
Stomach CancerPhase 1
KR
Panolos Bioscience, Inc.Panolos Bioscience, Inc.
25 Oct 2023
NeoplasmsPreclinical
KR
SAMSUNG BIOLOGICS Co., Ltd.SAMSUNG BIOLOGICS Co., Ltd.
20 Sep 2023
NeoplasmsPreclinical
KR
NeoImmuneTech, Inc.NeoImmuneTech, Inc.
20 Sep 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free